TYLENOL PM
- Product NDC
- 50580-833
- 11-digit product format
- 505800833
- Labeler code
- 50580
- Product ID
- 50580-833_5def488c-5857-81d7-e063-6294a90ac270
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-25
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 1000; 50 mg/30mL; mg/30mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 50580-833-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 50580-833-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 50580-833-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 50580-833-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 50580-833-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 50580-833-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 50580-833-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 50580-833-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 50580-833-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 50580-833-01 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYLENOL PM
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 1000 mg/30mL |
| DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44e8a92a-748b-4dc3-ae8d-176a350ac83d | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-833-01 | ML - Milliliter | 50580-833 | 4eb50548-bfd6-4ca0-8b96-8e53a76d98be | 1 | 2018-10-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin | ASPIRIN | Chain Drug Marketing Association | 0e3be5f4-bc1b-4b44-a86a-ace89f6ee592 | 2024-12-02 | Warnings | M013 |
| St. Joseph Chewable Low Dose Aspirin | ASPIRIN | Foundation Consumer Healthcare LLC | 248cd302-e380-4837-bdae-9df620b67e8a | 2024-12-02 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 2d98e390-4f2a-41cc-b307-3d2f6a3700dd | 2024-12-02 | Warnings | M013 |
| Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | AAA Pharmaceutical, Inc. | 409b5fcd-5880-4dda-85d8-26aeceb4f8ab | 2024-12-02 | Warnings | M013 |
| Aspirin | ASPIRIN | AAA Pharmaceutical, Inc. | c0c31523-c4c5-43c2-8d72-4d1456c720e9 | 2024-12-02 | Warnings | M013 |
| NOTTS - Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | VIVUNT PHARMA LLC | e6754f62-e3b2-773f-e053-2a95a90ad36a | 2024-12-02 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | a891896d-c9fa-4448-915a-e6b531157d22 | 2024-12-02 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | SAFEWAY | d2d15e06-e9eb-3d2b-e053-2995a90a1cec | 2024-12-02 | Warnings | M013 |
| Pain Relief Regular Strength | ACETAMINOPHEN | TopCo Associates LLC | c2d33352-431c-4683-a4fa-a54437e7b8d2 | 2024-12-02 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | TopCo Associates LLC | bdb01b3e-ad34-4003-9b9a-e83a2c0e90bb | 2024-12-02 | Warnings | M013 |
| Aspirin 81mg Adult Low Dose | ASPIRIN | TopCare | 14d010fb-c4a1-4c3d-942f-58719727bfc0 | 2024-12-02 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | CVS Pharmacy, Inc | c4473ee6-4e01-1ec2-e053-2995a90ac513 | 2024-12-02 | Warnings | M013 |
| Aspirin | ASPIRIN | Proficient Rx LP | 9c186289-e309-45e8-8934-1d0eae0375c2 | 2024-12-01 | Warnings | M013 |
| Childrens Chewable Acetaminophen | ACETAMINOPHEN | GERI-CARE PHARMACEUTICAL CORP | 22f63d62-c941-5b8f-e063-6394a90aeecd | 2024-11-28 | Warnings | M013 |
| Extra Strength Acetaminophen | ACETAMINOPHEN | Geri-Care Pharmaceutical Corp | 7a7b6318-b7d6-31b1-e053-2991aa0abf25 | 2024-11-28 | Warnings | M013 |
| Extra Strength Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | INGLES MARKETS, INC. | 27fd288e-c07a-617f-e063-6394a90a17a4 | 2024-11-28 | Warnings | M013 |
| BAYER Aspirin Original, TRAVEL BASIX | ASPIRIN | Lil' Drug Store Products, Inc. | 7f5d9ebe-8119-49a2-9380-eca18a5e5e85 | 2024-11-27 | Warnings | M013 |
| EXCEDRIN MIGRAINE | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | Jones Healthcare Group - Packaging Services, Inc | c4168e4d-3dfc-4e51-a32e-14704cb59c66 | 2024-11-27 | Warnings | M013 |
| TYLENOL Extra Strength / TYLENOL Precise Cooling Pain Relief | ACETAMINOPHEN, LIDOCAINE, MENTHOL | Kenvue Brands LLC | 2611e984-0dd5-bda1-e063-6394a90a559a | 2024-11-26 | Warnings | M013 |
| First Aid Only Extra-Strength Non-Aspirin | ACETAMINOPHEN | Acme United Corporation | 6891d57a-10a6-53de-e053-2a91aa0ac7c2 | 2024-11-26 | Warnings | M013 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-833-01 | 50580083301 | 240 mL in 1 BOTTLE (50580-833-01) | 240 ml | 2018-06-25 | 0000-00-00 | No | No | Current |